We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$31.9B
AUM Growth
+$2.38B
Cap. Flow
+$1.7B
Cap. Flow %
5.32%
Top 10 Hldgs %
15.42%
Holding
3,195
New
265
Increased
1,619
Reduced
1,032
Closed
182

Sector Composition

Rank Sector Weight
1 Healthcare 9.59%
2 Technology 8.36%
3 Consumer Staples 8.04%
4 Financials 7.78%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMM icon
2876
Navios Maritime Partners
NMM
$2.26B
$41K ﹤0.01%
2,093
-319
-13% -$6.86K
CME icon
2877
CALL
CME Group
CME
$94.8B
$40K ﹤0.01%
44,900
+6,800
+18% +$643K
JPM icon
2878
CALL
JPMorgan Chase
JPM
$950B
$40K ﹤0.01%
89,700
+18,300
+26% +$1.14M
MSFT icon
2879
CALL
Microsoft
MSFT
$3.71T
$40K ﹤0.01%
121,500
-7,300
-6% -$379K
PQ
2880
DELISTED
Petroquest Energy Inc Wd
PQ
$40K ﹤0.01%
+11,925
New +$35.1K
AAPL icon
2881
CALL
Apple
AAPL
$4.57T
$39K ﹤0.01%
334,400
+8,400
+3% +$209K
LSTA icon
2882
Lisata Therapeutics
LSTA
$9.55M
$39K ﹤0.01%
439
+8
+2% +$736
OPK icon
2883
PUT
Opko Health
OPK
$1.02B
$39K ﹤0.01%
65,000
-20,900
-24% -$212K
CRK icon
2884
Comstock Resources
CRK
$3.94B
$38K ﹤0.01%
9,000
KOPN icon
2885
Kopin
KOPN
$791M
$38K ﹤0.01%
+17,200
New +$33.2K
BAA
2886
DELISTED
Banro Corporation Common Stock
BAA
$38K ﹤0.01%
13,135
+2,685
+26% +$8.11K
PKG icon
2887
CALL
Packaging Corp of America
PKG
$22.8B
$37K ﹤0.01%
+22,700
New +$1.48M
OREX
2888
DELISTED
Orexigen Therapeutics, Inc.
OREX
$37K ﹤0.01%
8,647
+400
+5% +$1.81K
GERN icon
2889
Geron
GERN
$949M
$36K ﹤0.01%
13,400
IBIO icon
2890
iBio
IBIO
$70M
$36K ﹤0.01%
10
BAC.WS.A
2891
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
$36K ﹤0.01%
10,446
+400
+4% +$1.54K
FALC
2892
DELISTED
FalconStor Software Inc
FALC
$36K ﹤0.01%
34,535
-5,000
-13% -$6.37K
RAS
2893
DELISTED
RAIT Financial Trust
RAS
$36K ﹤0.01%
11,532
CNXR
2894
DELISTED
Connecture, Inc.
CNXR
$35K ﹤0.01%
+15,351
New +$31.9K
AST
2895
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$34K ﹤0.01%
+14,078
New +$50.9K
CIVI
2896
DELISTED
Civitas Resources
CIVI
$32K ﹤0.01%
+142
New +$42.5K
CVEO icon
2897
Civeo
CVEO
$318M
$32K ﹤0.01%
+1,483
New +$30.3K
GEN icon
2898
CALL
Gen Digital
GEN
$17.5B
$32K ﹤0.01%
17,900
-2,000
-10% -$36K
HOG icon
2899
CALL
Harley-Davidson
HOG
$2.71B
$32K ﹤0.01%
56,400
+23,900
+74% +$1.1M
SWK icon
2900
CALL
Stanley Black & Decker
SWK
$15.7B
$32K ﹤0.01%
14,700
+4,400
+43% +$489K

Similar funds

Raymond James & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Raymond James & Associates held 3,195 positions worth $31.9B, up 8.1% from $29.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $1.7B of net new capital in Q2 2016, opening 265 new positions and adding to 1,619 existing holdings. Its largest new stake was Schwab US REIT ETF: 467,710 shares worth $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.6% of assets, up from 9% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was WisdomTree Europe Hedged Equity Fund, an estimated $43.1M trimmed.

  • Raymond James & Associates's largest Q2 2016 buy was Schwab US REIT ETF: 467,710 shares worth $10.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2016, an estimated $107M increase.
  • Raymond James & Associates's biggest Q2 2016 reduction was WisdomTree Europe Hedged Equity Fund, cutting an estimated $43.1M.
  • Raymond James & Associates fully exited ADT Corp in Q2 2016, selling an estimated $34.4M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $31.9B portfolio in Q2 2016.
  • Raymond James & Associates opened 265 new positions and closed 182 in Q2 2016.
  • Raymond James & Associates's portfolio value rose 8.1% quarter-over-quarter to $31.9B.

Based on Raymond James & Associates's 13F filing for Q2 2016, filed 11 Aug 2016.